Delivery Order SPE2DB22D3301-SPE2DB24FX4FP
Award Date
10/24/23
Potential Completion Date
10/25/23
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,525.17 firm fixed-price delivery order is for the supply of 0.75 mg Everolimus tablets. The contract has a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $56,004.64 from the Defense Logistics Agency (DLA). The contract provides for the delivery of Everolimus 5 mg tablets to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,141.89 Firm Fixed Price Delivery Order covers the supply of Everolimus 1 mg tablets for a period ending on February 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,888.67 firm fixed-price delivery order is for the supply of 60-count tablet packages of the drug Everolimus 0.75 mg. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,842.64 firm-fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets. The contract has an ultimate completion date of November 24, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Everolimus 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,406.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, with a focus on supporting the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,753.70 firm fixed-price delivery order contract covers the supply of Everolimus 0.75 mg tablets for medical treatment. The contract has an ultimate completion date of March 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,488.37 firm fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets, with a period of performance through March 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Everolimus 5 mg tablets. The contract, valued at $1,902.66, was awarded by the Defense Logistics Agency (DLA) on November 16, 2023, with a completion date of November 17, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.83 firm fixed-price delivery order is for the supply of Everolimus 0.75 mg tablets, with a completion date of February 13, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...